7-(3-Phenylpropoxy)-9-n-butyl-1-methyl-beta-carboline

ID: ALA2314672

PubChem CID: 71575156

Max Phase: Preclinical

Molecular Formula: C25H28N2O

Molecular Weight: 372.51

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCn1c2cc(OCCCc3ccccc3)ccc2c2ccnc(C)c21

Standard InChI:  InChI=1S/C25H28N2O/c1-3-4-16-27-24-18-21(28-17-8-11-20-9-6-5-7-10-20)12-13-22(24)23-14-15-26-19(2)25(23)27/h5-7,9-10,12-15,18H,3-4,8,11,16-17H2,1-2H3

Standard InChI Key:  FWCJAYKBKGZZHP-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   10.5723  -22.8319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9067  -22.0846    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.4225  -21.4213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6120  -21.5095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2818  -22.2567    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5004  -22.5073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7955  -22.0987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0864  -22.5073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0864  -23.3245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7955  -23.7331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5004  -23.3245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2818  -23.5784    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.7578  -22.9159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0525  -23.4910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6769  -24.2931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4932  -24.3074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3773  -23.7331    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6716  -23.3209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9621  -23.7265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8893  -25.0222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7064  -25.0365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2562  -23.3149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5467  -23.7205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8431  -23.3054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1341  -23.7103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1302  -24.5283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8412  -24.9398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5472  -24.5325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
  6 11  2  0
 11 12  1  0
 12 13  1  0
  5 13  2  0
  1 13  1  0
  1 14  1  0
 15 16  1  0
 12 15  1  0
 18 19  1  0
 17 18  1  0
  9 17  1  0
 16 20  1  0
 20 21  1  0
 19 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
M  END

Alternative Forms

Associated Targets(Human)

OS-RC-2 (487 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bel-7402 (4577 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KB (17409 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CWR22R (2180 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-251 (51189 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-375 (9258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
769-P (491 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SCaBER (64 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BGC-823 (3035 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
786-0 (47912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 372.51Molecular Weight (Monoisotopic): 372.2202AlogP: 6.31#Rotatable Bonds: 8
Polar Surface Area: 27.05Molecular Species: NEUTRALHBA: 3HBD:
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 6.04CX LogP: 5.85CX LogD: 5.83
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.34Np Likeness Score: -0.34

References

1. Cao R, Fan W, Guo L, Ma Q, Zhang G, Li J, Chen X, Ren Z, Qiu L..  (2013)  Synthesis and structure-activity relationships of harmine derivatives as potential antitumor agents.,  60  [PMID:23291116] [10.1016/j.ejmech.2012.11.045]

Source